During the past decade, Krankenhaus Maria-Hilf Stadtlohn conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Maria-Hilf Stadtlohn" are "Lymphoma" (1 trials) and "Spinal Disorders/Injuries" (1 trials). Many other conditions were trialed in "Krankenhaus Maria-Hilf Stadtlohn" in a lesser frequency.

Most popular intervention types in "Krankenhaus Maria-Hilf Stadtlohn" are "Biological" (1 trials), "Drug" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Spinal Surgery" (1 trials), "cyclophosphamide" (1 trials), "doxorubicin hydrochloride" (1 trials), "pegfilgrastim" (1 trials) and "pharmacological study" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Maria-Hilf Stadtlohn" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Krankenhaus Maria-Hilf Stadtlohn". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Krankenhaus Maria-Hilf Stadtlohn, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Maria-Hilf Stadtlohn, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".